Current Studies of Immunotherapy on Glioblastoma
Journal Title: Journal of Neurology and Neurosurgery - Year 2014, Vol 1, Issue 1
Abstract
Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy has historically struggled to translate it into effective clinical treatments. Better understanding is needed of the various regulatory and co-stimulatory factors in the glioblastoma patient for more efficient immunotherapy treatments. The tumor microenvironment is anatomically shielded from normal immune-surveillance by the blood-brain barrier, irregular lymphatic drainage system, and it’s in a potently immunosuppressive environment. Immunotherapy can potentially manipulate these forces effectively to enhance anti-tumor immune response and clinical benefit. New treatments utilizing the immune system show promise in terms of targeting and efficacy. This review article attempts to discuss current practices in glioblastoma treatment, the theory behind immunotherapy, and current research into various clinical trials.
Authors and Affiliations
Arabinda Das
Keywords
Related Articles
- EP ID EP192186
- DOI 10.19104/jnn.2014.104
- Views 136
- Downloads 0
Current Studies of Immunotherapy on Glioblastoma
Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alte...
Cerebral Amyloid Angiopathy -Related Inflammation (CAA-ri): Is Steroid/Imunosuppressive Therapy Beneficial?
Background: Cerebral amyloid angiopathy (CAA) is an important cause of intracerebral hemorrhage. Brain amyloid-related imaging abnormalities (ARIA) can be classified into two groups; those with edema or sulcal effacement...